InfuSystem's Pain Management Business Set to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026.

InfuSystem Holdings' pain management business will receive separate payment under the NOPAIN Act starting January 1, 2026, for the CADD-Solis and Sapphire infusion pumps. The Centers for Medicare and Medicaid Services added these pumps to the list of qualifying products for separate payment. This move is part of CMS' strategy to combat the opioid crisis by promoting safer pain management alternatives. The payment may encourage healthcare providers to consider adding InfuSystem's service to their formulary, potentially driving volume growth in the pain management business.